Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

Obicetrapib

Cat. No.: 0225LY-1240
Appearance: Solid
Purity: ≥99%
Identity: Confirmed by NMR, and LC-MS.
Size:
Obicetrapib
Add to basket

Product Overview

Description: Obicetrapib functions as a pharmacological inhibitor of the cholesteryl ester transfer protein (CETP).
Synonym: TA8995; AMG899; Obicetrapib (free base); AMG 899; AMG-899; Obicetrapib; TA-8995; 866399-87-3; DEZ-001; 4-[2-[[3,5-bis(trifluoromethyl)phenyl]methyl-[(2R,4S)-1-ethoxycarbonyl-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinolin-4-yl]amino]pyrimidin-5-yl]oxybutanoic acid; 1-Ethyl (2R,4S)-4-[[[3,5-bis(trifluoromethyl)phenyl]methyl][5-(3-carboxypropoxy)-2-pyrimidinyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-1(2H)-quinolinecarboxylate; (2R,4S)-4-((3,5-Bis(trifluoromethyl)benzyl)(5-(3-carboxypropoxy)pyrimidin-2-yl)amino)-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester; 1(2H)-Quinolinecarboxylic acid, 4-(((3,5-bis(trifluoromethyl)phenyl)methyl)(5-(3-carboxypropoxy)-2-pyrimidinyl)amino)-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, 1-ethyl ester, (2R,4S)-; 1(2H)-Quinolinecarboxylic acid, 4-[[[3,5-bis(trifluoromethyl)phenyl]methyl][5-(3-carboxypropoxy)-2-pyrimidinyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, 1-ethyl ester, (2R,4S)-; 4-((2-((3,5-bis(trifluoromethyl)benzyl)((2R,4S)-1-(ethoxycarbonyl)-2-ethyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-yl)amino)pyrimidin-5-yl)oxy)butanoic acid; 4-{[2-({[3,5-bis(trifluoromethyl)phenyl]methyl}[(2R,4S)-1-(ethoxycarbonyl)-2-ethyl-6-(trifluoromethyl)-1,2,3,4-tetrahydroquinolin-4-yl]amino)pyrimidin-5-yl]oxy}butanoic acid
CAS No.: 866399-87-3
Compound CID: 11498596
Formula: C32H31F9N4O5
Formula Weight: 722.6

Specification

Relative Density: 1.394 g/cm3
Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: Obicetrapib can be used in clinical pharmacology to study the next-generation inhibition of CETP for lowering LDL cholesterol.

Library Information

Target: CETP
Receptor: CETP
Pathways: Metabolism
Plate Number: AOCL-16
Plate Location: h7
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 10mM DMSO
DMSO Max Solubility: 7.23 mg/mL; 10.01 mM
Inquiry
0
Inquiry Basket

Copyright © Protheragen. All rights reserves.